Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors

Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors

US Patent 10905688 · Granted Feb 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
LRRK2 inhibitors2024
Leucine-rich repeat kinase 2 (LRRK2) inhibitors2024
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
LRRK2 inhibitors2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines2023